Sidebotham, P D, Skeldon, I, Chambers, T L et al. · British journal of hospital medicine · 1994
This study looked at young people with severe, long-lasting fatigue that didn't improve with standard treatments. The researchers compared adolescents who had ME/CFS that was difficult to manage with those who responded better to care. The findings help doctors understand which young patients may need different or more intensive approaches to treatment.
Understanding refractory ME/CFS in adolescents is critical because young people with treatment-resistant illness face prolonged disability during crucial developmental years. This early research helps identify which young patients may need specialized management strategies and highlights the clinical heterogeneity within ME/CFS, supporting the need for personalized treatment approaches.
This study does not prove what causes refractory ME/CFS or establish that any particular treatment approach will work for resistant cases. As a case-control study without detailed methodology described, it cannot establish causation and may be limited by small sample size, selection bias, or incomplete follow-up data. The findings represent associations rather than definitive clinical guidance.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →